Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: COMBINATION_PRODUCT: Neoadjuvant therapy: TCbHPy|COMBINATION_PRODUCT: Neoadjuvant therapy: TCbHP
Sponsor: The First Affiliated Hospital with Nanjing Medical University